T. Rowe Price Investment Management, Inc. Cytokinetics Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 9,689,987 shares of CYTK stock, worth $457 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
9,689,987
Previous 8,138,677
19.06%
Holding current value
$457 Million
Previous $441 Million
16.03%
% of portfolio
0.31%
Previous 0.28%
Shares
8 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$692 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$555 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$367 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$305 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC4.83MShares$228 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.44B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...